Manufacturer record
VADSP Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
17 batches manufactured by VADSP Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
17 records linked to VADSP Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets IP | VT251527Mfg 2025-09 · Exp 2027-02 | The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic AcidAssay | CDL,KolkataState lab | Jul 2026 |
| Thiamine Riboflavin, Niacinamide, Cynocobalamin & Liver Crude Injection (LIVGROW) Vetrinary Injection. | VL250515Mfg 2026-02 · Exp 2028-01 | The sample does not conform to the claim with respect to Assay of Cynocobalamin (Nil) and Riboflavin (Nil)Assay | DTL JaipurState lab | Jun 2026 |
| Cefixime Dispersible Tablet IP | VT240492Mfg 2024-05 · Exp 2026-04 | The sample does not conform to the IP with respect to Assay of Cefixime Trihydrate eq. to Anhydrous Cefixime.Assay | DTL BikanerState lab | Jun 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP | VT251451Mfg 2025-09 · Exp 2027-02 | The Sample does not meets the Specifications wrt. Assay and Dissolution of Clavulanic acid as per IP.Assay | State Lab, DCL, TelanganaState lab | Jun 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP | VT251183Mfg 2025-08 · Exp 2027-01 | Dissolution test and content of Clavulanic AcidDissolution | SDT&RL, BhubaneswarState lab | Jun 2026 |
| Cefpodoxime Proxetil Tablets IP | VT241139Mfg 2024-08 · Exp 2026-07 | The sample does not conform to the I.P. with respect to Assay of Cefpodoxime Proxetil eq. to Cefpodoxime.Assay | DTL JodhpurState lab | May 2026 |
| Aceclofenac and Thiocolchicoside Tablets | VT251855Mfg 2025-11 · Exp 2027-10 | The sample does not conform to IP 2022 requirements w.r.t Assay of ThiocolchicosideAssay | DTL,Dalgate Srinagar kashmirState lab | May 2026 |
| Cefuroxime Axetil Tablets IP | VT252942Mfg 2026-03 · Exp 2028-02 | The sample does not conform to the IP with respect to Assay.Assay | DTL JaipurState lab | Apr 2026 |
| Cefpodoxine Proxetil Tablets IP | VT242312Mfg 2024-12 · Exp 2026-11 | The sample does not conform to the IP as it does not contain Cefpodoxime (Nil)Other | DTL JaipurState lab | Apr 2026 |
| Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets | VT252296Mfg 2025-12 · Exp 2027-05 | The sample does not conform to the claim as it does not contain Clavulanic Acid (Nil).Other | DTL JaipurState lab | Apr 2026 |
| Ofloxacin and Ornidazole Tablets IP | VT250644Mfg 2025-06 · Exp 2027-05 | The sample does ot conforms to claim as per IP 2022 in respect to the Test of Dissolution of Ofloxacin & Ornidazole.Dissolution | DTL, BADDI H.PState lab | Nov 2025 |
| Cefixime and Ofloxacin Tablets | VT240794Mfg 2024-07 · Exp 2026-06 | AssayAssay | DTL, JaipurState lab | Aug 2025 |
| Cefixime &Ofloxacin Tablets (CEFXEN-O) | VT240794Mfg 2024-07 · Exp 2026-06 | The sample does not conform to the claim with respect to assay of CefiximeAssay | DTL,Jaipur (State Lab)State lab | May 2025 |
| Amoxymoon CV-625 [Amoxycillin and Potassium Clavulanate Tablets IP] | VT 241704Mfg 2024-10 · Exp 2026-03 | It fails the tests ?Assay? and ?Dissolution? for Clavulanic Acid as per IP, as specified in the Laboratory Protocol .Assay | DTL ThiruvananthapuramState lab | Dec 2024 |
| B - Cidal 625 | UT232859Mfg 2024-03 · Exp 2025-08 | The content of Clavulanic acid is not with in the limit of ?Schedule V? of Drugs and Cosmetics Act & Rules thereunderOther | DTL ThiruvananthapuramState lab | Sep 2024 |
| Zonerab (Rabeprazole Sodium Gastro- Resistant Tablets I.P.) | ZRB?12Mfg 2019-07 · Exp 2021-06 | Dissolution in Acid Stage & AssayAssay | CDL KolkataCDSCO lab | Jul 2020 |
| Chloramphenicol and Dexamethasone Sodium Eye Drops (POLYMICIN EYE DROPS) | POLY-07Mfg 2018-07 · Exp 2020-06 | Assay of Chloramphenicol, and Dexamethasone Sodium PhosphateAssay | RDTL ChandigarhCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.